ghk-cu injection clinical trial human Frontiers ghk cu human clinical trial

The PEGylation can be attributed to the increase in hydrodynamic size, which leads to a reduction in renal filtration due to PEG conjugation (122)

It also carries essentially no risk at the doses typically used in compounded formulations, making it a low-downside addition even when the benefit is uncertain

It has a remarkable ability to stimulate follicular activity, increase the size of hair follicles, and extend the anagen (growth) phase of the hair cycle

This happens because the skin needs time to adjust to changes in bacterial activity and inflammation levels

Because of their targeted nature, peptides have become increasingly popular among athletes, active adults, and individuals looking to support performance, recovery, body composition, and overall wellness

All the authors have read and agreed to the published version of the manuscript